TELO

Telomir Pharmaceuticals, Inc. (Ticker: TELO) is a pre-clinical-stage biopharmaceutical company based in Baltimore, Maryland, dedicated to advancing innovative therapeutic solutions targeting human stem cell disorders. The company is focused on harnessing proprietary technologies to develop novel treatments that have the potential to improve health outcomes in regenerative medicine. With a strong emphasis on research and development, Telomir aims to position itself at the forefront of stem cell therapy, addressing significant unmet medical needs and creating value for stakeholders as it moves toward commercialization.